XML 24 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Liability Attributable to Warrants
3 Months Ended
Mar. 31, 2013
Liability Attributable to Warrants [Abstract]  
Liability Attributable to Warrants
4.  Liability Attributable to Warrants
 
The exercise price of the warrants we issued in September 2011 in conjunction with the private placement of our common stock (the "2011 Private Placement") and the warrants we issued in October 2011 in connection with our engagement of an intellectual property firm (ipCapital Group) could, in certain circumstances, be reset to below-market value. Accordingly, we have concluded that such warrants are not indexed to our common stock; therefore, the fair value of the warrants was recorded as a liability upon their issuance.
 
Under ASC 820, "Fair Value Measurement," we re-measure the fair value of our outstanding warrants at every balance sheet date. As an integral part of the re-measurement process, we reevaluate each of the assumptions used, and when circumstances change or we become aware of new information affecting any of our assumptions, we adjust those assumptions accordingly. During the three months ended March 31, 2013 two investors in the 2011 private placement exercised an aggregate 462,500 warrants.  While closing our books for the three months ended March 31, 2013, we reevaluated our internal assumptions based on historic and recent exercise patterns and analysis of our stock performance. Based on the work performed, we concluded that a lowering of our estimated exercise factor for the warrants issued in conjunction with the 2011 private placement from 10 to 4 was appropriate (see the assumptions used, as set forth in the tables, below).
 
Changes in fair value of the 2011 Private Placement warrants liability are recognized in other expense and changes in the fair value of the warrants issued to ipCapital are recognized as a component of general and administrative expense in the condensed consolidated statement of operations.
 
We used the exercise price of the warrants, as well as the fair market value of its common stock, to determine the fair value of its warrants.  The exercise price for warrants issued in conjunction with the 2011 private placement ranged between $0.20 and $0.26, per share, and was $0.26 per share for the warrants issued to ipCapital. The fair market value of the Company's common stock was $0.63 and $0.18 per share as of March 31, 2013 and  2012, respectively.
 
We used a binomial pricing model to determine the fair value of our warrants as of March 31, 2013 and December 31, 2012, the balance sheet date, using the following assumptions:
 
 
 
For the Three Months Ended December 31, 2012
 
Estimated Volatility
 
 
Annualized Forfeiture Rate
 
 
Expected Option Term (Years)
 
 
Estimated Exercise Factor
 
 
Risk-Free Interest Rate
 
 
Dividends
 
2011 Private Placement
 
 
145
%
 
 
 
 
 
3.42
 
 
 
4
 
 
 
0.36
%
 
 
 
ipCapital
 
 
145
%
 
 
 
 
 
3.54
 
 
 
4
 
 
 
0.36
%
 
 
 
 
 


For the Year Ended December 31, 2012
 
Estimated Volatility
Annualized Forfeiture Rate
Expected Option Term (Years)
Estimated Exercise Factor
Risk-Free Interest Rate
Dividends
2011 Private Placement
159% - 202%
3.67 – 4.42
10
0.47% - 1.04%
ipCapital
163% - 201%
3.80 – 4.54
10
0.47% - 1.04%

 
 
The following table is a reconciliation of the warrants liability measured at fair value using significant unobservable inputs (Level 3) for the three months ended March 31, 2013:  During the three month period ended March 31, 2013 warrants were exercised for 462,000 shares.
 
Warrants liability – December 31, 2012 fair value
 
$
7,390,100
 
Change in fair value of warrant liability recorded in other expenses
 
 
3,448,700
 
Accretion of warrant liability recorded in general and administrative expense
 
 
73,500
 
Reclassification of warrants liability to equity from the exercise of warrants
 
 
(215,100
)
Warrants liability – March 31, 2013 fair value
 
$
10,697,200
 
 
The following table reconciles the number of warrants outstanding for the periods ended March 31, 2013 and 2012, respectively.
 
For the Period Ended March 31, 2013
 
 
Beginning Outstanding
 
 
Exercised
 
 
Ending Outstanding
 
2011 Private Placement
 
 
23,075,000
 
 
 
462,500
 
 
 
22,612,500
 
ipCapital
 
 
400,000
 
 
 
 
 
 
400,000
 
Total
 
 
23,475,000
 
 
 
462,500
 
 
 
23,012,500
 
 
For the Period Ended March 31, 2012
 
 
Beginning Outstanding
 
 
Exercised
 
 
Ending Outstanding
 
2011 Private Placement
 
 
23,075,000
 
 
 
 
 
 
23,075,000
 
ipCapital
 
 
400,000
 
 
 
 
 
 
400,000
 
Total
 
 
23,475,000
 
 
 
 
 
 
23,475,000